Idiosyncratic drug reactions: The reactive metabolite syndromes

Lancet

Volumn 356, Issue 9241, 2000, Pages 1587-1591

  Knowles, Sandra R ^a   Uetrecht, Jack ^a   Shear, Neil H ^a  

^a SUNNYBROOK RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOPURINOL; ANTIBIOTIC AGENT; ANTICONVULSIVE AGENT; ANTIHISTAMINIC AGENT; CEFACLOR; CEFPROZIL; CHLORPROMAZINE; CORTICOSTEROID; DRUG METABOLITE; IMMUNOGLOBULIN; ISONIAZID; METHYLDOPA; MINOCYCLINE; NONSTEROID ANTIINFLAMMATORY AGENT; PENICILLAMINE; PROCAINAMIDE; SULFONAMIDE;

BACTERIAL INFECTION; DIFFERENTIAL DIAGNOSIS; DRUG HYPERSENSITIVITY; FEVER; HUMAN; INFLUENZA; LUPUS ERYTHEMATOSUS; LYMPHADENOPATHY; MALAISE; PATHOGENESIS; PHARYNGITIS; PRIORITY JOURNAL; REVIEW; SERUM SICKNESS; SYMPTOMATOLOGY; SYNDROME;

EID: 0034605712     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(00)03137-8     Document Type: Article

References (47)

1. Severe adverse cutaneous reactions to drugs
2. Serious adverse reactions induced by minocycline: A report of 13 patients and review of the literature
3. Anticonvulsant hypersensitivity syndrome: In vitro assessment of risk
4. Lamotrigine-associated anticonvulsant hypersensitivity syndrome
5. Risk of serious cutaneous disorders after initiation of use of phenytoin, carbamazepine, or sodium valproate: A record linkage study
6. Familial occurrence of hypersensitivity to phenytoin
7. In-vitro assessment of hypersensitivity syndrome associated with sorbinil
8. Anticonvulsant hypesensitivity syndrome
9. Drug-induced hypothyroidism: The thyroid as a target organ in hypersensitivity reactions to anticonvulsants and sulfonamides
10. Clinical assessment of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme
11. Medication use and risk of Stevens-Johnson syndrome or toxic epidermal necrolysis
12. A prospective clinical and immunologic analysis of patients with serum sickness
13. Serum sickness in children after antibiotic exposure: Estimates of occurrence and morbidity in a Health Maintenance Organization population
14. Cholestatic hepatitis due to antibacterial combination of amoxicillin and clavulanic acid (Augmentin)
15. Serum sickness-like reactions associated with cefprozil therapy
16. Drug-related lupus
17. Minocycline-induced autoimmune hepatitis and systemic lupus erythematosus-like syndrome
18. Histone antibodies in systemic lupus erythematosus: A possible diagnostic tool
19. Drug-induced lupus
20. Minocycline-induced lupus in adolescents
21. Antineutrophil cytoplasmic antibody-positive polyarteritis associated with minocycline therapy
22. Anticonvulsant toxicity in vitro: Possible role of arene oxides
23. Characterization of the microsomal epoxide hydrolase gene in patients with anticonvulsant adverse drug reactions
24. Genetic analysis of microsomal epoxide hydrolase in patients with carbamazepine hypersensitivity
25. Free radical intermediates of phenytoin and related teratogens. Prostaglandin H synthase-catalyzed bioactivation, electron paramagnetic resonance spectrometry and photochemical product analysis
26. Bioactivation of phenytoin by human cytochrome P450: Characterization of the mechanism and targets of covalent adduct formation
27. Detection of 2-hydroxyiminostilbene in the urine of patients taking carbamazepine and its oxidation to a reactive iminoquinone intermediate
28. Sulfamethoxazole is metabolized to the hydroxylamine in humans
29. Role of drug disposition in drug hypersensitivity: A chemical, molecular, and clinical perspective
30. New concepts in immunology relevant to idiosyncratic drug reactions: The 'danger hypothesis' and innate immune system
31. Safety of lamotrigine
32. Advances in the treatment of prophylaxis of Pneumocystis carinii pneumonia
33. Oral therapy for Pneumocystis carinii pneumonia in AIDS: A randomized double blind trial comparing trimethoprim and sulfamethoxazole with dapsone and trimethoprim
34. High incidence of a concentration-dependent skin reaction in children treated with phenytoin
35. Minocycline related lupus
36. Treatment of toxic epidermal necrolysis and Stevens-Johnson syndrome in children
37. Management of acquired bullous skin diseases
38. Effectiveness of early therapy with corticosteroids in Stevens-Johnson syndrome: Experience in 41 cases and a hypothesis regarding pathogenesis
39. Management of Stevens-Johnson syndrome and toxic epidermal necrolysis in children
40. Randomised comparison of thalidomide versus placebo in toxic epidermal necrolysis
41. Programmed cell death, apoptosis and killer genes
42. Apoptosis as a mechanism of keratinocyte death in toxic epidermal necrolysis
43. Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin
44. In vivo and in vitro testing for adverse drug reactions
45. Carbamazepine-induced drug rashes: Diagnostic value of patch tests depends on clinico-pathologic presentation
46. Cefaclor-associated serum sickness-like disease: Eight cases and review of the literature
47. Cefaclor serum sickness